Results 21 to 30 of about 280,575 (305)

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer

BMC Gastroenterology, 2020
Background Biliary tract cancers (BTC) have a poor prognosis even after curative resection because of frequent local and distant recurrences. Therefore, the importance of adjuvant therapy in BTC has been advocated to improve outcomes. However, the choice
Hyera Kim, Mi Hwa Heo, Jin Young Kim
doaj   +1 more source

Adjuvant Chemotherapy of Breast Cancer [PDF]

Breast Care, 2009
rence.’ The NCCN Practice Guidelines in Oncology Breast Cancer leave it open, intermediate and high-risk node negative patients are assigned to category 1: chemotherapy regimens comprising taxane and non-taxane containing regimens. Thus, guidelines currently do not provide real help.
Nitz, Ulrike, Cardoso, Fatima, Gnant, Michael, Thomssen, Christoph   +3 more
openaire   +3 more sources

Node-positive breast cancer: Which are the best chemotherapy regimens? [PDF]

, 2008
Breast cancer-associated mortality has been significantly reduced since the 1990s, mainly because of early diagnosis and systemic therapeutic interventions.
Bauerfeind, Ingo, Rack, Brigitte, Harbeck, Nadia, Friese, Klaus, Janni, Wolfgang, Sommer, Harald   +5 more
core   +1 more source

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study

BMC Cancer, 2018
Background There is no consensus regarding the optimal time to initiate adjuvant chemotherapy after surgery for stage III colon cancer, and the relevant postoperative complications that cause delays in adjuvant chemotherapy are unknown.
Peng Gao, Xuan-zhang Huang, Yong-xi Song, Jing-xu Sun, Xiao-wan Chen, Yu Sun, Yu-meng Jiang, Zhen-ning Wang   +7 more
doaj   +1 more source

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

Cancer Medicine, 2018
To identify impacts of different combined regimens of stereotactic body radiation therapy (SBRT) and chemotherapy on survival of patients with locally advanced pancreatic cancer (LAPC) and factors correlated with determinations of different combinations.
Xiaofei Zhu, Dongchen Shi, Fuqi Li, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, Shuiwang Qing, Fang Fang, Zhen Jia, Huojun Zhang   +10 more
doaj   +1 more source

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery [PDF]

, 2010
BACKGROUND: In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented.
Lyman, Gary H., Lyman, Gary H, Szucs Thomas D, Culakova Eva, Szucs, Thomas D., Thomas D Szucs, Pettengell, Ruth, Szucs, Thomas D, Eva Culakova, Lyman, GH, Culakova, Eva, Ruth Pettengell, Matthias Schwenkglenks, Pettengell, R, Schwenkglenks, Matthias, Szucs, TD, Gary H Lyman, Pettengell Ruth, Culakova, E, Schwenkglenks Matthias, Lyman Gary H, Lyman, G H, Szucs, T D, Schwenkglenks, M   +23 more
core   +1 more source

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study

BMC Cancer, 2009
Background There is currently no standard adjuvant therapy for patients with curatively resected extrahepatic biliary tract cancer (EHBTC). The aim of this study was to analyze the clinical features and outcomes between patients undergoing adjuvant ...
Kim Tae-You, Im Seock-Ah, Jang Jin-Young, Chie Eui, Oh Do-Youn, Lim Kyu-Hyoung, Kim Sun-Whe, Ha Sung, Bang Yung-Jue   +8 more
doaj   +1 more source

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial [PDF]

, 2006
Oral capecitabine (Xeloda^®) is an effective drug with favourable safety in adjuvant and metastatic colorectal cancer.
F Coxon, T S Maughan, Douillard, J.Y., Lesniewski-Kmak, K, Bertetto, O., Jelic, S., Maughan, T.S., Dufour, A., J-Y Douillard, Johnston, P G, C Twelves, Díaz-Rubio, E., Cassidy, J, Twelves, C., Jelic, S, P G Johnston, Figer, A, G Fountzilas, W Scheithauer, Patel, K K, Malzyner, A, Fountzilas, G., K Lesniewski-Kmak, A Malzyner, Maughan, TS, Bustová, I, Cowell, W., Garrison, L.P., Twelves, C, Díaz-Rubio, E, O Bertetto, W Cowell, Beham, A, S Jelic, Maughan, Tim, Dufour, P, J J McKendrick, Scheithauer, W., Douillard, JY, Cowell, W, Lesniewski-Kmak, K., Garrison, L P, Bustová, I., Beham, A., Fountzilas, G, Johnston, PG, A Beham, Garrison, LP, K K Patel, Patel, KK, I Bustová, Cassidy, J., McKendrick, J.J., Bertetto, O, L P Garrison, Coxon, F., Patel, K.K., Douillard, J-Y, P Dufour, A Figer, Johnston, P.G., Scheithauer, W, Coxon, F, Maughan, T S, McKendrick, JJ, J Cassidy, E Díaz-Rubio, McKendrick, J J, Malzyner, A., Figer, A.   +69 more
core   +1 more source

Ifosfamide with regional hyperthermia in soft-tissue sarcomas [PDF]

, 2003
For high-risk soft tissue sarcomas (HR-STS) of adults, new treatment strategies are needed to improve outcome with regard to local control and overall survival.
M. Schlemmer, Wendtner, Clemens-Martin, C.M. Wendtner, R.D. Issels, Schlemmer, M., Issels, Rolf-Dieter   +5 more
core   +1 more source

Variations in the body mass index in Brazilian women undergoing adjuvant chemotherapy for breast cancer [PDF]

Revista Brasileira de Ginecologia e Obstetrícia, 2014
PURPOSE:To evaluate variations in the body mass index in patients undergoing adjuvant chemotherapy for breast cancer, and to associate these changes with patient's age and adjuvant chemotherapy regimen.METHODS:We performed a retrospective cohort study in
Marcos Desídérío Ricci, Maria Carolina Formigoni, Lucia Maria Martins Zuliani, Denis Seiiti Aoki, Bruna Salani Mota, José Roberto Filassi, José Roberto Morales Piato, Edmund Chada Baracat   +7 more
doaj   +2 more sources